THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

J&J buys new-generation stent maker

$1.4b deal may boost Boston Scientific rival

By Stephen Heuser
Globe Staff / November 18, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In an effort to create a more powerful rival to Boston Scientific Corp., healthcare giant Johnson & Johnson said late Thursday night it would pay $1.4 billion for Conor Medsystems Inc. of California, developer of a new-generation stent to repair coronary arteries. (Full article: 455 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass